Total: 448 results found.
Page 5 of 23
Cannabis Science Initiates Scientific Cultivation Programs to Test Multiple Strains of Cannabis to Obtain Extract Formulations for Clinical Drug Development Targeting Multiple Critical Ailments Starting with Cancer and Neurological Disorders
Created on 2018-06-14 16:20:55
Cannabis Science Initiates Pre-Clinical Studies on Cannabinoid Formulations in Neurological Diseases Including Sleep Disorders with the Highly Reputable Institute for Health and Science on Ageing - INRCA - in Italy
Created on 2018-06-14 16:19:45
Cannabis Science, Inc. (CBIS) Encouraged by Florida Medical Cannabis Voter Support of 88 Percent; Florida Referendum in November Seen as Key Tipping Point
Created on 2018-06-14 16:18:36
Cannabis Science In Final Negotiations To Establish Its First Medical Cannabis Facilities In Canada
Created on 2018-06-14 16:17:15
Cannabis Science, Inc. (CBIS) Increases Equity Position to 50.1% in Michigan Green Technologies LLC, Positioning Company as Leader in Evolving Michigan Medical Cannabis and Hemp Industries
Created on 2018-06-14 16:15:57
Cannabis Science, Inc. (CBIS) Increases Equity Position to 50.1% in Michigan Green Technologies LLC, Positioning Company as Leader in Evolving Michigan Medical Cannabis and Hemp Industries
Created on 2018-06-13 23:33:37
Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France
Created on 2018-06-13 23:32:31
Cannabis Science, Inc. (CBIS) In Final Negotiations To Acquire British Columbia Company That Has Submitted 'Marihuana For Medical Purposes' License Application To Health Canada
Created on 2018-06-13 23:31:37
Cannabis Science Provides Updated Guidance on its Current Pre-Clinical Drug Development Programs Beginning with the Scientific Cannabis Cultivation Programs in Europe and North America, Testing Multiple Cannabis Strains for Multiple Critical Ailments
Created on 2018-06-13 23:30:41
Cannabis Science, Inc. (CBIS) And Unistraw Holdings Join Forces To Produce Proprietary Formulations Delivering A Wide Array Of Unique Cannabis Extracts And Pure Cannabinoid-Based Products
Created on 2018-06-13 23:29:42
Cannabis Science, Inc. (CBIS) Signs Drug Development and Laboratory Services Agreement with ImmunoClin Corporation (IMCL); Collaboration to Advance Clinical Studies and Formulations of the Company's Proprietary Cannabinoid Based Products
Created on 2018-06-13 23:28:35
Cannabis Science Releases Positive Laboratory Results From Both The EU Certified As Well As Its Own Unique Cannabis Strains Grown In Its Spain Operations
Created on 2018-06-13 23:27:35
Cannabis Science (CBIS) Ready For A Prosperous And Healthy New Year: 'The Best Is Yet To Come'
Created on 2018-06-13 23:24:00
CBIS to Release 8 Initial Cannabis-Based Products, Synergistically Produced, Distributed and Marketed Across California, Spain, and the Netherlands, For Pre-Clinical Studies and Immediate Self-Medicating Patient Usage for Ailments
Created on 2018-06-13 23:19:29
Cannabis Science, Inc. (CBIS) Gets Set to Release its 8 Initial Cannabis-Based Products Produced and Distributed in California, Spain, and the Netherlands for Self-Medicating Patient Usage for Critical Ailments and Pre-Clinical Studies
Created on 2018-06-13 23:17:34
Cannabis Science (CBIS) Issues Upbeat Report on its Subsidiary, Michigan Green Technologies (MGT), as Historic Michigan Milestone is Reached with New Hemp Legislation
Created on 2018-06-13 23:12:17
Cannabis Science (CBIS) Provides Guidance on the Company's New Year and Products, Developments and 'Initiatives in Action' for 2015
Created on 2018-06-13 21:38:47
Cannabis Science President & CEO, Raymond C. Dabney is named Vice Chair of the CFA Africa Healthcare Infrastructure Initiative Committee
Created on 2018-06-13 21:37:55